Drug intelligence / Profile preview

Xiere Huazhuo Formula

Development stage: Preclinical
Lead developer: Pudong New Area Traditional Chinese Medicine Development Foundation
Modality: Small Molecules
Administration: Oral

Overview

Xiere Huazhuo Formula is an empirical Traditional Chinese Medicine (TCM) formulation developed by Professor Ding Xueping. It is currently being investigated for the treatment of obesity, with clinical trials comparing its effectiveness and safety against Orlistat.

Other names: 泄热化浊颗粒

Beyond the preview

Go deeper on Xiere Huazhuo Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiere Huazhuo Formula.

Explore the full profile